LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Evolution of renal replacement therapy in Mexico in the last 10 years.

    Méndez-Durán, Antonio

    Nefrologia

    2021  Volume 41, Issue 1, Page(s) 82–83

    Language English
    Publishing date 2021-03-08
    Publishing country Spain
    Document type Letter
    ZDB-ID 2837917-2
    ISSN 2013-2514 ; 2013-2514
    ISSN (online) 2013-2514
    ISSN 2013-2514
    DOI 10.1016/j.nefroe.2020.02.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Evolution of renal replacement therapy in Mexico in the last 10 years.

    Méndez-Durán, Antonio

    Nefrologia

    2020  Volume 41, Issue 1, Page(s) 82–83

    Title translation Evolución del tratamiento sustitutivo de la función renal en México en los últimos 10 años.
    Language Spanish
    Publishing date 2020-05-07
    Publishing country Spain
    Document type Letter
    ZDB-ID 2837917-2
    ISSN 2013-2514 ; 2013-2514
    ISSN (online) 2013-2514
    ISSN 2013-2514
    DOI 10.1016/j.nefro.2020.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Renoprotección. A propósito del Día Mundial del Riñón.

    Méndez-Durán, Antonio / Duque-Molina, Célida / Teva-Luna, Roberto / Avilés-Hernández, Ricardo

    Revista medica del Instituto Mexicano del Seguro Social

    2023  Volume 61, Issue 5, Page(s) 631–637

    Abstract: The World Kidney Day was founded in 2003 by doctor Joel D. Kopple, American nephrologist, who in the session in the Congress of the International Federation of Kidney Foundations explained the need to implement the celebration on a day that alludes to ... ...

    Title translation Renoprotection. About World Kidney Day.
    Abstract The World Kidney Day was founded in 2003 by doctor Joel D. Kopple, American nephrologist, who in the session in the Congress of the International Federation of Kidney Foundations explained the need to implement the celebration on a day that alludes to this organ, in order to direct preventive actions for kidney disease and raise awareness in the medical community and the general population on the importance of caring for the kidneys. 3 years later, the proposal was accepted and as of 2006 World Kidney Day is celebrated. The diffusion is found throughout the world and in each place there are talks, courses, workshops, cultural activities and even marathons related to the prevention, diagnosis and treatment of kidney disease. Chronic kidney disease (CKD) is a disorder with a chronic, degenerative, and lethal evolution. Managing CKD requires a large amount of human, financial, and infrastructure resources. It impairs the quality of life and negatively affects survival. On the other hand, it leads to dialysis and kidney transplant treatments, which are expensive enough to put any health institution at financial risk, especially those most vulnerable. The main idea of these non-profit international organizations is to promote the well-being and improve the quality of life of people with CKD with and without dialysis, and to promote kidney transplantation as the first treatment option.
    MeSH term(s) Humans ; Quality of Life ; Kidney ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/prevention & control ; Kidney Transplantation ; Renal Dialysis
    Language Spanish
    Publishing date 2023-09-04
    Publishing country Mexico
    Document type English Abstract ; Journal Article
    ZDB-ID 732133-8
    ISSN 2448-5667 ; 0443-5117 ; 0484-7849
    ISSN (online) 2448-5667
    ISSN 0443-5117 ; 0484-7849
    DOI 10.5281/zenodo.8316457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Inhibidores del sistema renina-angiotensina-aldosterona. Diferencias farmacológicas.

    Méndez-Durán, Antonio

    Revista medica del Instituto Mexicano del Seguro Social

    2011  Volume 49, Issue 1, Page(s) 45–52

    Abstract: The activation of the renin-angiotensin-aldosterone cascade is a mechanism that generates high blood pressure. The structure has been identified and can be blocked through specific enzymatic pathways or receptors. We have a diversity of medications that ... ...

    Title translation Pharmacological differences between inhibitor drugs of the renin-angiotensin aldosterone system.
    Abstract The activation of the renin-angiotensin-aldosterone cascade is a mechanism that generates high blood pressure. The structure has been identified and can be blocked through specific enzymatic pathways or receptors. We have a diversity of medications that act on this system. It is useful to develop the skill in clinical practice for selecting a drug from a wide variety. Renin-angiotensin system inhibitors share many pharmacological and pharmacokinetic characteristics but not all them are equivalent. Knowledge based on scientific evidence allows the clinician to choose the ideal drug for each patient.
    MeSH term(s) Angiotensin Receptor Antagonists/antagonists & inhibitors ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensins/antagonists & inhibitors ; Humans ; Hypertension/drug therapy ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Renin/antagonists & inhibitors ; Renin-Angiotensin System/drug effects
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Angiotensins ; Mineralocorticoid Receptor Antagonists ; Renin (EC 3.4.23.15)
    Language Spanish
    Publishing date 2011-01
    Publishing country Mexico
    Document type English Abstract ; Journal Article
    ZDB-ID 732133-8
    ISSN 0443-5117 ; 0484-7849
    ISSN 0443-5117 ; 0484-7849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group.

    Correa-Rotter, Ricardo / Méndez Durán, Antonio / Vallejos, Augusto / Rico-Fontalvo, Jorge / Cusumano, Ana María / Rosa-Diez, Guillermo Javier / Sánchez Polo, Vicente / Goecke, Helmuth / Arango, José Javier / Cerón, Vanessa Villavicencio / Diná, Eliana / Fonseca, Fabio Hernández / Valdés, Régulo Adolfo / Vanoni, Miguel

    Kidney international reports

    2023  Volume 8, Issue 5, Page(s) 954–967

    Abstract: Chronic kidney disease (CKD) represents a major challenge for Latin American (LatAm) because of its epidemic proportions. Therefore, the current status and knowledge of CKD in Latin America is not clearly understood. Moreover, there is a paucity of ... ...

    Abstract Chronic kidney disease (CKD) represents a major challenge for Latin American (LatAm) because of its epidemic proportions. Therefore, the current status and knowledge of CKD in Latin America is not clearly understood. Moreover, there is a paucity of epidemiologic studies that makes the comparison across the countries even more difficult. To address these gaps, a virtual kidney expert opinion meeting of 14 key opinion leaders from Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, and Panama was held in January 2022 to review and discuss the status of CKD in various LatAm regions. The meeting discussed the following: (i) epidemiology, diagnosis, and treatment of CKD, (ii) detection and prevention programs, (iii) clinical guidelines, (iv) state of public policies about diagnosis and management of chronic kidney disease, and (v) role of innovative therapies in the management of CKD. The expert panel emphasized that efforts should be made to implement timely detection programs and early evaluation of kidney function parameters to prevent the development or progression of CKD. Furthermore, the panel discussed the importance of raising awareness among health care professionals; disseminating knowledge to the authorities, the medical community, and the general population about the kidney and cardiovascular benefits of novel therapies; and the need for timely updating of clinical practice guidelines, regulatory policies, and protocols across the region.
    Language English
    Publishing date 2023-02-27
    Publishing country United States
    Document type Journal Article
    ISSN 2468-0249
    ISSN (online) 2468-0249
    DOI 10.1016/j.ekir.2023.02.1082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Documento de consenso sobre el uso de iSGLT2 en pacientes con enfermedad renal crónica y diabetes.

    Correa-Rotter, Ricardo / Rosas-Guzmán, Juan / Méndez-Durán, Antonio / Sebastián-Díaz, Mario A / Díaz-Avendaño, Odette Del C / Mehta-Pravin, Roopa / Alcocer-Gamba, Marco A

    Gaceta medica de Mexico

    2021  Volume 158, Issue M2, Page(s) M1–M12

    Abstract: La enfermedad renal crónica (ERC) del paciente diabético es frecuentemente una consecuencia directa de la diabetes mellitus (DM) de larga evolución y se la conoce como nefropatía diabética. En México cerca del 50% de los pacientes en terapia sustitutiva ... ...

    Title translation Consesus document in the use of SGLT inhibitors in patients with diabetes and chronic kidney disease.
    Abstract La enfermedad renal crónica (ERC) del paciente diabético es frecuentemente una consecuencia directa de la diabetes mellitus (DM) de larga evolución y se la conoce como nefropatía diabética. En México cerca del 50% de los pacientes en terapia sustitutiva de la función renal tienen ERC por DM, y este porcentaje podría aumentar en los próximos años. Nuevas opciones terapéuticas, combinadas con cambios en el estilo de vida, han mejorado el control de la glucemia y pueden contribuir sustancialmente a retrasar la aparición o la progresión a estadios avanzados de la ERC. Las sociedades científicas internacionales han elaborado guías clínicas para el diagnóstico y manejo de la nefropatía diabética, sin embargo, en algunos puntos estas recomendaciones no se adaptan a la realidad mexicana. Se presentan las conclusiones de un consenso realizado por especialistas mexicanos sobre diabetes y ERC, con especial énfasis en el uso de los inhibidores del cotransportador de sodio-glucosa.
    Chronic kidney disease (CKD) in the diabetic patient is mainly a consequence of long-term diabetes mellitus itself. In Mexico approximately 50% of patients on dialysis are diabetics and this will could increase in the coming years. New therapeutic options available, combined with lifestyle changes, have improved glycemic control and may contribute to delay the onset as well as the progression of CKD. International scientific societies have developed clinical guidelines for the diagnosis and management of CKD in diabetics, although in some points, these recommendations are not adapted to the Mexican reality. We hereby present the conclusions of the consensus reached by Mexican specialists on diabetic nephropathy.
    MeSH term(s) Diabetes Mellitus/epidemiology ; Humans ; Mexico/epidemiology ; Renal Dialysis ; Renal Insufficiency, Chronic/epidemiology ; Retrospective Studies
    Language English
    Publishing date 2021-12-30
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 425456-9
    ISSN 0016-3813
    ISSN 0016-3813
    DOI 10.24875/GMM.M21000595
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Instituto Mexicano del Seguro Social gives dialysis therapies to 426 students without cost

    Méndez-Durán, Antonio / Ignorosa-Luna, Manuel Humberto / Pérez-Aguilar, Gilberto / Rivera-Rodríguez, Francisco Jesús / López-Ocaña, Luis Rafael

    Revista medica del Instituto Mexicano del Seguro Social

    2018  Volume 56, Issue 2, Page(s) 163–166

    Abstract: Background: The Instituto Mexicano del Seguro Social (IMSS) is the institution with the greatest health coverage in Mexico. In adherence to existing and committed to provide specialized services to specific populations (vulnerable age groups, such as ... ...

    Title translation El Instituto Mexicano del Seguro Social otorga terapias de diálisis sin costo a 426 estudiantes
    Abstract Background: The Instituto Mexicano del Seguro Social (IMSS) is the institution with the greatest health coverage in Mexico. In adherence to existing and committed to provide specialized services to specific populations (vulnerable age groups, such as children and young people in primary, secondary and higher education, productive and without social security educational training), this gives the renal replacement therapy -peritoneal dialysis and hemodialysis- at no cost to students.
    Methods: Cross-sectional and retrospective study conducted from 1 to 30 September 2016; Census Patients with Chronical Renal Failure, sociodemographic and type of therapy are identified; direct costs are estimated.
    Results: At 25 August 2016 to 16 426 was addressed to 26 years old, 279 male (65%) and 147 female (35%). The causes IRC were congenital problems 194 (45%), chronic glomerular diseases 111 (26%), diabetes mellitus type 1, 58 (14%), polycystic kidneys 7 (2%) and undetermined causes 56 (13%). 78 patients received CAPD, APD 208, 61 HD and 79 HD IM MS. The average annual investment per patient was 75 827.47 mexican pesos; the costs were in CAPD dialysis modality $ 41 931.20, DPA $ 64 123.20, HD intramural $ 33 301.32 and extramural $ 165 360.00; which generated a cash cost of $ 32 302 503.40 mexican pesos
    Conclusions: These data demonstrate the Institute commitment to society in granting health, preserve life and improve the quality of life of Mexicans and stage of health risk posed by the IRC.
    MeSH term(s) Academies and Institutes ; Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Health Care Costs ; Humans ; Kidney Failure, Chronic/economics ; Kidney Failure, Chronic/therapy ; Male ; Mexico ; Renal Dialysis/economics ; Retrospective Studies ; Social Security ; Students ; Young Adult
    Language Spanish
    Publishing date 2018-06-13
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 732133-8
    ISSN 2448-5667 ; 0443-5117 ; 0484-7849
    ISSN (online) 2448-5667
    ISSN 0443-5117 ; 0484-7849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic-Cardio-Renal Perspective for the Primary Care Physician.

    Mehta, Roopa / Pichel, Daniel / Chen-Ku, Chih Hao / Raffaele, Pablo / Méndez Durán, Antonio / Padilla, Francisco / Arango Alvarez, Jose Javier / Esteban Costa Gil, José / Esteban Gómez Mesa, Juan / Giorgi, Mariano / Lahsen, Rodolfo / Sposito, Andrei C

    Diabetes therapy : research, treatment and education of diabetes and related disorders

    2020  Volume 12, Issue 1, Page(s) 1–20

    Abstract: Growing scientific evidence from studies on type 2 diabetes (T2D) has recently led to a better understanding of the associated metabolic-cardio-renal risks. The large amount of available information makes it essential to have a practical guide that ... ...

    Abstract Growing scientific evidence from studies on type 2 diabetes (T2D) has recently led to a better understanding of the associated metabolic-cardio-renal risks. The large amount of available information makes it essential to have a practical guide that summarizes the recommendations for the initial management of patients with T2D, integrating different aspects of endocrinology, cardiology, and nephrology. The expert consensus presented here does not attempt to summarize all the evidence in this regard but rather attempts to define practical summary recommendations for the primary care physician to improve the clinical prognosis and management of patients with T2D, while ensuring economic sustainability of health systems, beyond glycemic control.
    Language English
    Publishing date 2020-12-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2566702-6
    ISSN 1869-6961 ; 1869-6953
    ISSN (online) 1869-6961
    ISSN 1869-6953
    DOI 10.1007/s13300-020-00961-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Estado actual de las terapias sustitutivas de la función renal en el Instituto Mexicano del Seguro Social.

    Méndez-Durán, Antonio / Ignorosa-Luna, Manuel Humberto / Pérez-Aguilar, Gilberto / Rivera-Rodríguez, Francisco Jesús / González-Izquierdo, José Jesús / Dávila-Torres, Javier

    Revista medica del Instituto Mexicano del Seguro Social

    2016  Volume 54, Issue 5, Page(s) 588–593

    Abstract: Background: The IMSS performs systematically the data updating of patients with renal replacement therapy (RRT) by an electronic record management referred as: Census patients with Chronical Renal Failure (CIRC) which aims to meet the prevalence of ... ...

    Title translation Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social.
    Abstract Background: The IMSS performs systematically the data updating of patients with renal replacement therapy (RRT) by an electronic record management referred as: Census patients with Chronical Renal Failure (CIRC) which aims to meet the prevalence of patients with chronic renal failure and the behavior of RRTat the IMSS.
    Methods: A retrospective study includes 212 secondary hospitals with dialysis programs, with both pediatric and adult patients. CIRC data obtained from January to December 2014, number and nominal bonds of peritoneal dialysis (PD) and hemodialysis (HD). Prevalence of patients and therapies by delegation, distribution by gender and age, cause of kidney disease, morbidity and mortality were identified.
    Results: 55,101 patients, of whom 29,924 were male (54 %) and 25,177 women (46 %), mean age was 62.1 years (rng: 4-90); 20,387 were pensioners (36.9 %). The causes of renal failure were: diabetes 29,054 (52.7 %), hypertension 18,975 (34.4 %), chronic glomerulopathies 3,951 (7.2 %), polycystic kidneys 1,142 (2.1 %), congenital 875 (1.6 %) and other 1,104 (2 %). HD was given in 41 % of patients, and the remaining 59 % DP; the annual cost was 5,608,290,622 pesos.
    Conclusions: The increased prevalence of diabetes mellitus and hypertension affect the onset of RRT, which show a catastrophic financial outlook for the Institute.
    MeSH term(s) Academies and Institutes ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Health Care Costs/statistics & numerical data ; Humans ; Kidney Failure, Chronic/economics ; Kidney Failure, Chronic/etiology ; Kidney Failure, Chronic/therapy ; Male ; Mexico ; Middle Aged ; Renal Dialysis/economics ; Renal Dialysis/methods ; Renal Dialysis/statistics & numerical data ; Renal Dialysis/utilization ; Retrospective Studies ; Social Security ; Young Adult
    Language Spanish
    Publishing date 2016-09
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 732133-8
    ISSN 0443-5117 ; 0484-7849
    ISSN 0443-5117 ; 0484-7849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Low triiodothyronine is associated with elevation of N-terminal pro-brain natriuretic peptide (NT-proBNP) and mortality in dialysis patients.

    Prado-Uribe, María Del Carmen / Ventura, María-de-Jesús / Ávila-Díaz, Marcela / Mora, Carmen J / Méndez-Durán, Antonio / Villanueva-Noches, Diana / Cisneros, Alejandra / Ilabaca, Begoña / Cueto-Manzano, Alfonso / García-Contreras, Fernando / Lindholm, Bengt / García-López, Elvia / Paniagua, Ramón

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

    2017  Volume 37, Issue 6, Page(s) 598–607

    Abstract: Background: Low thyroid hormone (TH) levels and myocardial damage are common in dialysis patients and are associated with mortality. However, little is known about the role of THs on myocardial damage as has been described in primary thyroid diseases. ... ...

    Title translation La disminución de triyodotironina se asocia con la elevación del péptido natriurético cerebral N-terminal y con la mortalidad en pacientes en diálisis.
    Abstract Background: Low thyroid hormone (TH) levels and myocardial damage are common in dialysis patients and are associated with mortality. However, little is known about the role of THs on myocardial damage as has been described in primary thyroid diseases. The aim of this study was to explore the potential relationship between low total triiodothyronine (total T3) and biomarkers of myocardial damage and the effect of their interaction on mortality, to ascertain if cardiovascular damage is the link between low THs and the risk of death in dialysis patients with CKD.
    Material and methods: TH plasma levels, nutritional markers, inflammation and myocardial damage were studied in 296 patients undergoing peritoneal dialysis or haemodialysis, who were followed up for 16 months to ascertain the association between biochemical variables and mortality.
    Results: Low total T3 levels were found in 45% of patients, which was inversely correlated with C-reactive protein (CRP) and NT-proBNP, and directly correlated with albumin and transferrin. Diabetes, CRP and total T3 were risk factors for all-cause mortality, and CRP, NT-proBNP and total T3 for cardiovascular mortality.
    Conclusions: Low total T3 levels are common in dialysis patients and are associated with inflammation, malnutrition and myocardial damage. The latter may be the link between low THs and all-cause and cardiovascular mortality.
    MeSH term(s) Adult ; Aged ; Biomarkers ; C-Reactive Protein/analysis ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality ; Diabetic Nephropathies/blood ; Diabetic Nephropathies/therapy ; Female ; Humans ; Infection/mortality ; Inflammation ; Kidney Failure, Chronic/blood ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/mortality ; Kidney Failure, Chronic/therapy ; Male ; Malnutrition/blood ; Malnutrition/complications ; Middle Aged ; Myocardium/pathology ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Peritoneal Dialysis/adverse effects ; Prognosis ; Prospective Studies ; Renal Dialysis/adverse effects ; Sampling Studies ; Serum Albumin/analysis ; Transferrin/analysis ; Triiodothyronine/blood ; Triiodothyronine/deficiency
    Chemical Substances Biomarkers ; Peptide Fragments ; Serum Albumin ; Transferrin ; pro-brain natriuretic peptide (1-76) ; Triiodothyronine (06LU7C9H1V) ; Natriuretic Peptide, Brain (114471-18-0) ; C-Reactive Protein (9007-41-4)
    Language Spanish
    Publishing date 2017-11
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 632512-9
    ISSN 1989-2284 ; 0211-6995
    ISSN (online) 1989-2284
    ISSN 0211-6995
    DOI 10.1016/j.nefro.2017.05.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top